Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management

Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management - Industrial Nitric oxide and Nitrogen gas inhalation for patients with congenital heart disease during the perioperative management

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010916

Enrollment

100

Registered

2013-06-10

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All Congenital Heart Desease

Interventions

Inhalation of the industrial Nitric oxide and Nitrogen gas

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Pulmonary hypertension by echocardiography

Exclusion criteria

Exclusion criteria: Patients without Pulmonary hypertension by echocardiography or those who has no congenital heart defect

Design outcomes

Primary

Measure	Time frame
Patient hemodynamics in perioperative period	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026